KUALA LUMPUR, Oct 14 -- Studies to determine the neutralising antibody levels (immunity) in COVID-19 patients are needed to see if they can be re-infected, besides the long-term and side effects on their organs.
Health director-general Tan Sri Dr Noor Hisham Abdullah said through the study, if there is a decline in antibody levels after three months of monitoring, patients were more likely to be infected again.
“If the antibody declines after three months, there is a possibility the patient can be re-infected. Or we will see if there are other studies on the long-term and side effects on certain organs after recovering,” he said in a virtual press conference posted on the Facebook page of the Health Ministry (MOH) today.
Yesterday via his Facebook page, Dr Noor Hisham invited former COVID-19 patients to participate in a medical research conducted by a group of researchers at the Institute of Medical Research (IMR).
He said the study was important to determine the level of neutralising antibodies (immunity) in the blood that could prevent COVID-19 bacteria from infecting previously infected patients.
Hence, Dr Noor Hisham called on patients to participate in the medical research titled: ‘Kajian Membujur Tindak Balas Antibodi Neutralisasi Dalam Kalangan Pesakit COVID-19 di Malaysia’.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
